1:30-5:30
|
TRACK A
|
Mind Traps - How Other Players can suck you into Making Bad Decisions
Many of the world's largest corporations such as Chevron, Pfizer, IBM, GE, Microsoft, and others use Game Theory to avoid being sucked into
making bad business decisions that result in dangerous outcomes for their most complicated issues and competitive challenges.
Come learn how other players can set you up into making bad decisions and how to avoid these situations. This highly requested seminar will help
you bring clarity to multi-player business problems using well-known 2x2 games and other illustrative principles of Game Theory. The applicability
of this event fits into the areas of corporate strategy, mergers and acquisitions, risk mitigation, IP licensing, and multi-player interactions along the
value chain.
Key take-aways from this session include:
- An understanding of Game Theory and its practical applications
- An advanced introduction to two of the best-known 2x2 games - Prisoner's Dilemma and Chicken - and how understanding these games
can help you develop strategies to avoid being trapped by other players in similar situations
- Knowing how to bring clarity to complex multi-player problems by applying Game Theory to unravel them
Dr. Niall Fraser, Founder and Principal Scientist, Open Options
|
| |
TRACK B
|
Leveraging CI to Optimize Late Lifecycle Strategic Planning
- Session 1: Introducing the role of CI in patent loss planning Illustrating the power of CI in patent loss mitigation, including techniques to
quantify it’s value.
- Session 2: Exploring the history of the generics industry Hurdles and access points for CI collection from generics companies.
- Session 3: Patent loss mitigation strategy Reviewing available strategic options to optimise loss of exclusivity.
- BREAK
- Session 4: Leveraging CI in patent loss planning Utilising CI to assessing generic competitor intensity and strategic intent, IP
innovations, geographic launch strategy, new opportunities and more.
- Session 5: Interactive case study and key take-aways
David Kuczenski, Director of Strategic Market Intelligence, Lifescience Dynamics
|
|
